tenk.fyi

Vaxcyte, Inc.

PCVXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$766.6M

65.2% YoY

EPS

$-5.63

48.2% YoY

Cash

$174.0M

55.2% YoY

FY 2025 · As of 2025-12-31